FIELD: chemistry.
SUBSTANCE: invention relates to salt of 2-ethyl-6-methyl-3-hydroxypyridine with fumaric acid, to method of its obtaining, as well as to method of metabolic malfunctions correction in case of pancreatic diabetes and functional malfunctions in myocardium.
EFFECT: obtaining of salt, which has metabolic and cardioprotective activity and can be applied in endocrinology, cardiology, emergency therapy and reanimation.
4 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIOXIDANT, ANTIHYPERGLYCEMIC, HYPOLIPIDEMIC AND ANTISHOCK N-ACETYLCYSTEINATE 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE | 2006 |
|
RU2357955C2 |
| 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE AND NICOTINIC ACID SALT, HAVING HYPOGLYCEMIC, HYPOLIPIDEMIC AND NEUROPROTECTIVE ACTIVITY AND SYNTHESIS METHOD THEREOF | 2010 |
|
RU2454406C2 |
| CORRECTIVE COMPOSITION FOR PATHOLOGIC CARBOHYDRATE, LIPID DISBOLISM AND ANTIOXIDANT ORGANISM STATE INVOLVEMENT | 2008 |
|
RU2360683C1 |
| METHOD FOR TREATING NEPHROANGIOPATHY COMBINED WITH ALLOXAN DIABETES IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2372898C1 |
| DIAGNOSTIC TECHNIQUE AND METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION IN VASCULAR COMPLICATIONS OF ALLOXAN DIABETES IN EXPERIMENT | 2010 |
|
RU2455702C1 |
| APPLICATION OF PHARMACEUTICAL COMPOSITION OF 2-MORPHOLINO-5-PHENYL-6H-1,3,4-THIADIAZINE WITH ASCORBIC ACID AS MEANS FOR ALLOXAN DIABETES CORRECTION | 2016 |
|
RU2626677C1 |
| ANTIDIABETIC AGENT | 1998 |
|
RU2150952C1 |
| USE OF COMPOUNDS OF 1,3,4-THIADIAZINE CLASS AS AGENT FOR CORRECTION OF EXPERIMENTAL ALLOXAN DIABETES | 2014 |
|
RU2597764C2 |
| AGENT FOR TREATMENT OF DISEASE CAUSED BY OXIDATIVE STRESS | 2018 |
|
RU2674286C1 |
| NATURAL PHOSPHOLIPID AGENT | 2008 |
|
RU2367443C1 |
